Search research articles
Contact Us
Filters
Showing results (81-90 of 168) with videos related to
Page
of 17
Sort By:
Journal of Translational Medicine
|
August 31, 2024
Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement
Medha Suman, Maja Löfgren, Susanne Fransson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 17, 2015
COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset
Karin Larsson, Anna Kock, Helena Idborg, et al.
Cancer Letters
|
June 11, 2005
Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations
Magnus Lindskog, Christian Spenger, Tomas Klason, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 2, 2008
Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy
Baldur Sveinbjörnsson, Agnes Rasmuson, Ninib Baryawno, et al.
International Journal of Cancer
|
October 15, 2013
Tropism of the in situ growth from biopsies of childhood neuroectodermal tumors following transplantation into experimental teratoma
Seema Jamil, Isabell Hultman, Jessica Cedervall, et al.
Carcinogenesis
|
May 17, 2011
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma
Bjørn Helge Haug, Jørn R Henriksen, Jochen Buechner, et al.
Neuropeptides
|
June 10, 2005
Galanin and galanin receptors in human cancers
Alexandra Berger, Radmila Santic, Cornelia Hauser-Kronberger, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 6, 2020
Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor-stroma drug targeting
Anna Kock, Filip Bergqvist, Julia Steinmetz, et al.
International Journal of Cancer
|
May 3, 2008
Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma
Janos Geli, Per Kogner, Fredrik Lanner, et al.
Plos One
|
January 4, 2013
Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma
Agnes Rasmuson, Lova Segerström, Maria Nethander, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 168) with videos related to
Sort By:
Page
of 17
Journal of Translational Medicine
|
August 31, 2024
Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement
Medha Suman, Maja Löfgren, Susanne Fransson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 17, 2015
COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset
Karin Larsson, Anna Kock, Helena Idborg, et al.
Cancer Letters
|
June 11, 2005
Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations
Magnus Lindskog, Christian Spenger, Tomas Klason, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 2, 2008
Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy
Baldur Sveinbjörnsson, Agnes Rasmuson, Ninib Baryawno, et al.
International Journal of Cancer
|
October 15, 2013
Tropism of the in situ growth from biopsies of childhood neuroectodermal tumors following transplantation into experimental teratoma
Seema Jamil, Isabell Hultman, Jessica Cedervall, et al.
Carcinogenesis
|
May 17, 2011
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma
Bjørn Helge Haug, Jørn R Henriksen, Jochen Buechner, et al.
Neuropeptides
|
June 10, 2005
Galanin and galanin receptors in human cancers
Alexandra Berger, Radmila Santic, Cornelia Hauser-Kronberger, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 6, 2020
Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor-stroma drug targeting
Anna Kock, Filip Bergqvist, Julia Steinmetz, et al.
International Journal of Cancer
|
May 3, 2008
Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma
Janos Geli, Per Kogner, Fredrik Lanner, et al.
Plos One
|
January 4, 2013
Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma
Agnes Rasmuson, Lova Segerström, Maria Nethander, et al.
Page
of 17